Carol A. Vallone
No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Sep 18: option exercise (1,086 DFTX shares).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every trade Carol A. Vallone reported
None in the last 12 months, as filed.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Carol A. Vallone's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 0 |
Alerts for Carol A. Vallone
Use this page
How to cite
Breakaway, Carol A. Vallone: Director at Definium Therapeutics (DFTX), Sep 18, 2026, getbreakaway.com/insiders/carol-a-vallone
Journalists: email support@getbreakaway.com for the data behind this page.